Life & Health INsurance

IFRS 17 isn’t just a regulatory update—it’s a strategic reset for life and health insurers. The new standard transforms how insurance contracts are measured, reported, and understood, demanding deeper integration between actuarial and finance teams, more granular data, and robust systems to support long-duration liabilities and complex cash flow projections.

Why IFRS 17 matters for life and health insurers.

Life and health insurance portfolios are uniquely impacted by IFRS 17 due to their long-term nature, embedded guarantees, and diverse contract structures. The standard introduces:

• Contractual Service Margin (CSM) tracking for long-duration contracts
• Granular cohort grouping based on risk and profitability
• Enhanced modeling of future cash flows and coverage units
• Cross-functional collaboration between actuarial, finance, and IT teams

These changes require insurers to rethink legacy systems, data architecture, and operational workflows. But they also unlock new opportunities to lead.

Strategic Benefits for Forward-Looking Insurers.

IFRS 17 enables life and health insurers to:

• Improve transparency in financial disclosures
• Enhance risk insights and liability valuation accuracy
• Deliver meaningful performance metrics that reflect economic reality
• Build investor confidence through standardized, comparable reporting

Insurers who embrace the change can reposition themselves as data-driven, investor-aligned organizations—ready to compete in a more transparent and performance-focused market.